Table 2 Baseline characteristics showed there was no statistical difference in the training group and test group.
Variables | Training group (n = 241) | Validation group (n = 103) | p Value |
---|---|---|---|
Age (years) | 40 (29, 54) | 48 (31, 55) | 0.112 |
Gender, n (male, %) | 131 (54.3) | 63 (61.1) | 0.244 |
SBP (mmHg) | 130 (119, 139) | 128 (120, 139) | 0.745 |
DBP (mmHg) | 81 (77, 90) | 80 (76, 86) | 0.278 |
RBC (1012/L) | 4.47 ± 0.63 | 4.52 ± 0.61 | 0.706 |
WBC (109/L) | 6.50 (5.30, 7.90) | 6.1 (5.2, 7.6) | 0.268 |
PLT (109/L) | 234 (197, 279) | 236 (186, 286) | 0.694 |
Eos (109/L) | 0.14 (0.08, 0.24) | 0.10 (0.06, 0.16) | 0.002 |
Eos% | 2.20 (1.40, 3.40) | 1.90 (1.05, 2.70) | 0.009 |
Hb (g/L) | 134.4 ± 20.6 | 133.3 ± 19.3 | 0.648 |
MCH (pg) | 30.4 (29.3, 31.5) | 30.2 (29.0, 31.4) | 0.863 |
MCHC (g/L) | 333 (327, 340) | 333 (327, 337) | 0.459 |
TP (g/L) | 46.6 (40.6, 54.4) | 45.8 (39.7, 53.0) | 0.648 |
ALB (g/L) | 24.0 (19.5, 30.8) | 22.9 (18.5, 31.0) | 0.439 |
TCHO (mmol/L) | 7.79 (5.70, 10.29) | 6.90 (5.09, 9.64) | 0.095 |
TG (mmol/L) | 2.08 (1.36, 2.94) | 1.85 (1.42, 2.50) | 0.219 |
LDL (mmol/L) | 5.14 (3.65, 7.88) | 4.89 (3.31, 8.19) | 0.472 |
HDL (mmol/L) | 1.41 (1.12, 1.79) | 1.32 (1.09, 1.78) | 0.490 |
eGFR (ml/min/1.73 m2) | 105.36 (88.83, 117.63) | 98.96 (80.73, 110.67) | 0.057 |
Scr (μmol/L) | 69.0 (58.5, 84.5) | 73.0 (60.0, 90.9) | 0.141 |
Urea (mmol/L) | 4.90 (3.80, 6.75) | 5.00 (4.00, 6.60) | 0.696 |
UA (μmol/L) | 309 (254, 377) | 324.0 (273, 395) | 0.094 |
CRP (mg/L) | 0.70 (0.00, 2.00) | 1.00 (0.17, 2.04) | 0.322 |
ESR (mm/h) | 37.0 (20.0, 68.0) | 44.0 (21.5, 68.0) | 0.418 |
C3 (g/L) | 1.37 (1.20, 1.56) | 1.32 (1.13, 1.52) | 0.159 |
C4 (g/L) | 0.31 (0.25, 0.37) | 0.32 (0.28, 0.37) | 0.097 |
24hTP (g) | 5.05 (2.38, 8.58) | 5.16 (2.55, 7.81) | 0.971 |
Urine volume (L) | 1.5 (1.0, 2.1) | 1.5 (1.0, 2.2) | 0.787 |
Thrombosis, n (%) | 4 (1.66) | 2 (1.94) | 1.000 |